<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01398202</url>
  </required_header>
  <id_info>
    <org_study_id>111</org_study_id>
    <nct_id>NCT01398202</nct_id>
  </id_info>
  <brief_title>Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults</brief_title>
  <official_title>Comparison of the Bioefficacy of Oral 25-hydroxyvitamin D3 and Vitamin D3 Supplements on Vitamin D Status in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University College Cork</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether a supplement of 25-hydroxyvitamin D is
      five-times more potent in raising vitamin D status (as reflected by serum 25(OH)D) compared
      to an equivalent amount of vitamin D3 in older adults. It will entail a 10 week
      supplementation study during winter months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The UK (McCance &amp; Widdowson) food composition tables suggests that 25-hydroxyvitamin D (which
      is present in some foods, albeit at very low concentrations, but which is also commercially
      available) may possess up to 5-times the activity of native vitamin D3 in food. Thus, in
      theory, each micogram of 25-hydroxyvitamin D consumed in the diet could boost vitamin D
      status up to five times most effectively compared to each microgram of native vitamin D in
      food. It is worth noting, however, that estimates of potency range from 2 to 5, depending on
      approach used, and that the real potency needs to be confirmed in a human study. This study
      aims to examine the biological activity of 25-hydroxyvitamin D (i.e., its potency relative to
      vitamin D3) as well as its effect on selected functional markers in a randomised,
      double-blind, human intervention trial in older adults.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25-hydroxyvitamin D concentration</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum parathyroid hormone</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum calcium adjusted for albumin</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Vitamin D Status as Reflected by Serum 25-hydroxyvitamin D</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 (20 microgram/day)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>25-hydroxyvitamin D (7 microgram/day)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>25-hydroxyvitamin D3 (20 micogram/day)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>20 micrograms per day for 10 weeks</description>
    <arm_group_label>Vitamin D3 (20 microgram/day)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>25-hydroxyvitamin D3</intervention_name>
    <description>7 microgram/day for 10 weeks</description>
    <arm_group_label>25-hydroxyvitamin D (7 microgram/day)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>25-hydroxyvitamin D (20 microgram/day)</intervention_name>
    <description>20 microgramday for 10 weeks</description>
    <arm_group_label>25-hydroxyvitamin D3 (20 micogram/day)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>0 ug vitamin D3/25-hydroxyvitamin D3/day for 10 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects will be eligible if they are 45+ years of age

          -  Body Mass Index (BMI) 19-30

        Exclusion Criteria:

          -  have hypercalcaemia

          -  chronic illness

          -  renal or liver disorders

          -  taking medications that might interact with vitamin D or metabolite

          -  drank more than &gt; 21 standards (male)/ 14 standards (female) of alcohol per week

          -  planning to change smoking habits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin D Cashman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College Cork</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University College Cork</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>July 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2011</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Cork</investigator_affiliation>
    <investigator_full_name>Kevin D. Cashman</investigator_full_name>
    <investigator_title>Professor of Food and Health</investigator_title>
  </responsible_party>
  <keyword>Vitamin D status</keyword>
  <keyword>25-hydroxyvitamin D</keyword>
  <keyword>Vitamin D3</keyword>
  <keyword>RCT</keyword>
  <keyword>Bio-efficacy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Hydroxycholecalciferols</mesh_term>
    <mesh_term>Calcifediol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

